The global Single-Use Bioreactor Market is estimated to be valued at US$ 1337.67 Mn in 2023 and is expected to exhibit a CAGR of 15 % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Single-use bioreactors are pre-sterilized, disposable bioreactors designed to culture cells and produce biopharmaceuticals with reduced risk of contamination. They offer advantages such as low capital investment, operational flexibility, and reduced validation requirements.
Market key trends:
The rising adoption of single-use technologies is a major trend fueling market growth. Single-use bioreactors provide advantages such as lower capital investments, reduced validation requirements, easy scale-up, and flexibility which has increased their adoption over traditional stainless-steel bioreactors. Their growing usage in personalized medicine and cell & gene therapy production is another key trend in the market. Furthermore, advancement in single-use bioreactor technologies to improve cell culture and bioprocessing efficiency is expected to open new opportunities over the forecast period.
Strength: Single-use bioreactors offer flexibility of use, reduced risk of cross-contamination, and lower capital costs compared to stainless steel bioreactors. They also allow for smaller production volumes without wastage.
Weakness: Single-use bioreactors have high production costs due to their disposable nature. Validating new types of single-use bags is also more complicated than validating stainless steel equipment.
Opportunity: Growing demand for biologics and increasing regulatory approvals is driving the need for increased bioproduction capacities. Single-use bioreactors help meet this demand by expediting drug development and reducing facility setup times.
Threats: Concerns around leachables and extractables from single-use materials could slow regulatory approvals. Additionally, dependence on a small number of vendors increases supply chain risks.
The global Single-Use Bioreactor Market Share is expected to witness high growth, exhibiting a CAGR of 15% over the forecast period, due to increasing demand for biologics and monoclonal antibodies.
Regional analysis: North America dominated the single-use bioreactor market in 2023 and is expected to remain the largest market during the forecast period. This is attributed to strong biopharmaceutical industry presence and growing R&D investments in the region. Asia Pacific is anticipated to be the fastest growing market due to rising biologics manufacturing capacities and lower operational costs.
Key players operating in the single-use bioreactor market are Sartorius AG, OmniBRx Biotechnologies, Merck KgaA, Solaris Biotechnology Srl, Eppendorf AG, Distek Inc., Celltainer Biotech BV, ABEC Inc., Thermo Fisher Scientific, and Danaher Corporation (Pall Corporation), among others. The market is concentrated and dominated by a few large players. Companies are focusing on product launches and expansion strategies to strengthen their market position.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it